155Tb production by cyclotrons: what level of 155Gd enrichment allows clinical applications?
Authors:
Francesca Barbaro,
Luciano Canton,
Nikolay Uzunov,
Laura De Nardo,
Laura Melendez-Alafort
Abstract:
BACKGROUND: 155Tb represents a potentially useful radionuclide for diagnostic medical applications, but its production remains a challenging problem. A recent experimental campaign, conducted with low-energy proton beams im**ing on a 155Gd target with 91.9% enrichment, demonstrated a significant co-production of 156gTb, a contaminant of great concern since its half-life is comparable to that of…
▽ More
BACKGROUND: 155Tb represents a potentially useful radionuclide for diagnostic medical applications, but its production remains a challenging problem. A recent experimental campaign, conducted with low-energy proton beams im**ing on a 155Gd target with 91.9% enrichment, demonstrated a significant co-production of 156gTb, a contaminant of great concern since its half-life is comparable to that of 155Tb and its high-energy gamma emissions severely impact on the dose released and on the quality of the SPECT images. Herein, the isotopic purity of the enriched 155Gd target necessary to minimize the co-production of contaminant radioisotopes, in particular 156gTb, was explored using various computational simulations. RESULTS: Starting from the recent data obtained with the 155Gd-enriched target, the co-production of other Tb radioisotopes besides 155Tb has been evaluated using the TALYS code. It was found that 156Gd, with an isotopic content of 5.87%, was the principal contributor to the co-production of 156gTb. The analysis also demonstrated that the maximum amount of 156Gd admissible for 155Tb production with a radionuclidic purity higher than 99% was 1%. A less stringent condition was obtained through computational dosimetry analysis, suggesting that a 2% content of 156Gd in the target can be tolerated to limit the dose increase to the patient below the 10% limit. Moreover, it has been demonstrated that the imaging properties of the produced 155Tb are not severely affected by this level of impurity in the target. CONCLUSIONS: 155Tb can be produced with a quality suitable for medical applications using low-energy proton beams and 155Gd-enriched targets if the 156Gd impurity content does not exceed 2%. Under these conditions, the dose increase due to the presence of contaminant radioisotopes remains below the 10% limit and good quality images, comparable to those of 111In, are guaranteed.
△ Less
Submitted 12 September, 2023;
originally announced September 2023.
Preliminary study of metabolic radiotherapy with 188Re via small animal imaging
Authors:
G. Baldazzi,
D. Bollini,
A. Muciaccio,
F. -L. Navarria,
G. Pancaldi,
A. Perrotta,
M. Zuffa,
P. Boccaccio,
N. Uzunov,
M. Bello,
D. Bernardini,
U. Mazzi,
G. Moschini,
M. Riondato,
A. Rosato,
F. Garibaldi,
R. Pani,
A. Antoccia,
F. de Notaristefani,
G. Hull,
V. Orsolini Cencelli,
A. Sgura,
C. Tanzarella
Abstract:
188Re is a beta- (Emax = 2.12 MeV) and gamma (155 keV) emitter. Since its chemistry is similar to that of the largely employed tracer, 99mTc, molecules of hyaluronic acid (HA) have been labelled with 188Re to produce a target specific radiopharmaceutical. The radiolabeled compound, i.v. injected in healthy mice, is able to accumulate into the liver after a few minutes. To study the effect of met…
▽ More
188Re is a beta- (Emax = 2.12 MeV) and gamma (155 keV) emitter. Since its chemistry is similar to that of the largely employed tracer, 99mTc, molecules of hyaluronic acid (HA) have been labelled with 188Re to produce a target specific radiopharmaceutical. The radiolabeled compound, i.v. injected in healthy mice, is able to accumulate into the liver after a few minutes. To study the effect of metabolic radiotherapy in mice, we have built a small gamma camera based on a matrix of YAP:Ce crystals, with 0.6x0.6x10 mm**3 pixels, read out by a R2486 Hamamatsu PSPMT. A high-sensitivity 20 mm thick lead parallel-hole collimator, with hole diameter 1.5 mm and septa of 0.18 mm, is placed in front of the YAP matrix. Preliminary results obtained with various phantoms containing a solution of 188Re and with C57 black mice injected with the 188Re-HA solution are presented. To increase the space resolution and to obtain two orthogonal projections simultaneously we are building in parallel two new cameras to be positioned at 90 degrees. They use a CsI(Tl) matrix with 1x1x5 mm**3 pixels read out by H8500 Hamamatsu Flat panel PMT.
△ Less
Submitted 1 June, 2005;
originally announced June 2005.
